Senores Pharmaceuticals IPO Sales, Profits, and other Financial Details - What you should know about the Senores Pharmaceuticals IPO

Senores Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Financial Information of Senores Pharmaceuticals Limited IPO
The Revenues from operations for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 1,833.53 Million, ₹ 2,173.42 Million, ₹ 390.21 Million and ₹ 146.31 Million respectively. The EBITDA for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 469.08 Million, ₹ 444.08 Million, ₹ 163.54 Million, and ₹ 24.13 Million, respectively. The Profit after Tax for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 239.43 Million, ₹ 327.08 Million, ₹ 84.33 Million, and ₹ 9.91 Million respectively.

Senores Pharmaceuticals Limited Financial Information (Restated Consolidated)

Amount in (₹ in Million)

Period Ended	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Reserve of Surplus	2,582.35	1,737.63	356.84	278.48
Total Assets	6,780.80	6,218.83	1,310.53	591.52
Total Borrowings	2,420.34	2,483.84	607.63	142.07
Fixed Assets	1,478.44	1,522.02	55.10	53.23
Cash	87.63	76.47	1	20.2
Net Borrowing	1,478.44	2,407.37	606.63	121.87
Revenue	1,833.53	2,173.42	390.21	146.31
EBITDA	469.08	444.08	163.54	24.13
PAT	239.43	327.08	84.33	9.91
EPS	7.2	12.21	6.65	1.81

Note 1:- RoE & ROCE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after completion of an Offer, given in FINANCIAL EXPRESS.